Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:INMD NASDAQ:MDXG NASDAQ:RXST NASDAQ:TCMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINMDInMode$15.31-1.1%$15.03$13.14▼$19.85$967.73M2.09771,722 shs491,677 shsMDXGMiMedx Group$6.76+1.8%$6.99$5.69▼$10.14$1.00B1.73620,762 shs529,555 shsRXSTRxSight$8.61+2.1%$8.79$6.32▼$55.57$352.29M1.17679,714 shs365,218 shsTCMDTactile Systems Technology$15.10+1.0%$13.89$8.61▼$21.10$336.61M1.04152,937 shs126,358 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for November 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINMDInMode-1.10%0.00%+2.41%+4.01%-14.18%MDXGMiMedx Group+1.81%+1.05%-4.65%-0.15%+20.28%RXSTRxSight+2.14%+4.49%-6.21%+8.03%-82.25%TCMDTactile Systems Technology+1.00%+3.92%+8.32%+43.13%+5.74%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINMDInMode$15.31-1.1%$15.03$13.14▼$19.85$967.73M2.09771,722 shs491,677 shsMDXGMiMedx Group$6.76+1.8%$6.99$5.69▼$10.14$1.00B1.73620,762 shs529,555 shsRXSTRxSight$8.61+2.1%$8.79$6.32▼$55.57$352.29M1.17679,714 shs365,218 shsTCMDTactile Systems Technology$15.10+1.0%$13.89$8.61▼$21.10$336.61M1.04152,937 shs126,358 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for November 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINMDInMode-1.10%0.00%+2.41%+4.01%-14.18%MDXGMiMedx Group+1.81%+1.05%-4.65%-0.15%+20.28%RXSTRxSight+2.14%+4.49%-6.21%+8.03%-82.25%TCMDTactile Systems Technology+1.00%+3.92%+8.32%+43.13%+5.74%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINMDInMode 2.00Hold$16.8510.06% UpsideMDXGMiMedx Group 2.50Moderate Buy$12.0077.51% UpsideRXSTRxSight 1.85Reduce$10.0016.14% UpsideTCMDTactile Systems Technology 2.43Hold$16.8311.48% UpsideCurrent Analyst Ratings BreakdownLatest TCMD, INMD, MDXG, and RXST Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/25/2025INMDInModeWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)10/25/2025MDXGMiMedx GroupWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)10/25/2025RXSTRxSightWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)10/25/2025TCMDTactile Systems TechnologyWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)10/10/2025INMDInModeCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$14.00 ➝ $16.0010/10/2025INMDInModeNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold10/8/2025INMDInModeWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)10/8/2025MDXGMiMedx GroupWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)10/8/2025RXSTRxSightWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)10/8/2025TCMDTactile Systems TechnologyWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)10/3/2025TCMDTactile Systems TechnologyLake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$23.50(Data available from 10/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINMDInMode$394.82M2.45$1.82 per share8.39$10.12 per share1.51MDXGMiMedx Group$348.88M2.87$0.33 per share20.40$1.31 per share5.16RXSTRxSight$139.93M2.52N/AN/A$6.98 per share1.23TCMDTactile Systems Technology$292.98M1.15$1.08 per share13.95$9.03 per share1.67Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINMDInMode$181.27M$2.476.208.41N/A44.50%18.38%16.35%11/5/2025 (Estimated)MDXGMiMedx Group$42.42M$0.2132.1921.13N/A8.84%23.03%17.09%10/29/2025 (Estimated)RXSTRxSight-$27.45M-$0.80N/AN/AN/A-21.93%-11.56%-10.31%11/6/2025 (Estimated)TCMDTactile Systems Technology$16.96M$0.6224.3517.98N/A5.06%7.72%5.59%11/3/2025 (Estimated)Latest TCMD, INMD, MDXG, and RXST EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/6/2025Q3 2025RXSTRxSight-$0.19N/AN/AN/A$25.63 millionN/A11/5/2025Q3 2025INMDInMode$0.32N/AN/AN/A$88.05 millionN/A11/3/2025Q3 2025TCMDTactile Systems Technology$0.16N/AN/AN/A$79.31 millionN/A10/29/2025Q3 2025MDXGMiMedx Group$0.07N/AN/AN/A$94.74 millionN/A8/7/2025Guidance UpdateRXSTRxSight-$0.04-$0.08-$0.04-$0.29$39.78 million$33.64 million8/4/2025Q2 2025TCMDTactile Systems Technology$0.09$0.14+$0.05$0.14$73.93 million$78.91 million7/30/2025Q2 2025INMDInMode$0.50$0.47-$0.03$0.42$98.45 million$95.60 million7/30/2025Q2 2025MDXGMiMedx Group$0.06$0.10+$0.04$0.06$90.79 million$98.61 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthINMDInModeN/AN/AN/AN/AN/AMDXGMiMedx GroupN/AN/AN/AN/AN/ARXSTRxSightN/AN/AN/AN/AN/ATCMDTactile Systems TechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINMDInModeN/A9.608.58MDXGMiMedx Group0.084.393.90RXSTRxSightN/A13.9312.70TCMDTactile Systems Technology0.113.793.36Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINMDInMode68.04%MDXGMiMedx Group79.15%RXSTRxSight78.78%TCMDTactile Systems Technology83.43%Insider OwnershipCompanyInsider OwnershipINMDInMode6.92%MDXGMiMedx Group1.70%RXSTRxSight9.57%TCMDTactile Systems Technology2.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINMDInMode48063.21 million58.84 millionOptionableMDXGMiMedx Group870147.96 million145.44 millionOptionableRXSTRxSight22040.92 million37.00 millionOptionableTCMDTactile Systems Technology1,03722.29 million21.74 millionOptionableTCMD, INMD, MDXG, and RXST HeadlinesRecent News About These CompaniesTactile Systems Technology, Inc. $TCMD Shares Sold by Janney Montgomery Scott LLCOctober 21, 2025 | marketbeat.comTactile Systems Technology, Inc. to Release Third Quarter Fiscal Year 2025 Financial Results on November 3, 2025October 20, 2025 | quiverquant.comQTactile Medical to Release Third Quarter of Fiscal Year 2025 Financial Results on November 3, 2025October 20, 2025 | globenewswire.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Consensus Recommendation of "Hold" from BrokeragesOctober 20, 2025 | marketbeat.comBlair William & Co. IL Trims Holdings in Tactile Systems Technology, Inc. $TCMDOctober 17, 2025 | marketbeat.comTactile Systems Technology's (TCMD) Hold (C) Rating Reiterated at Weiss RatingsOctober 9, 2025 | marketbeat.comLake Street Initiates Coverage of Tactile Systems Technology (TCMD) with Buy RecommendationOctober 4, 2025 | msn.comTactile Systems Technology (NASDAQ:TCMD) Earns Buy Rating from Analysts at Lake Street CapitalOctober 3, 2025 | marketbeat.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Average Recommendation of "Hold" from AnalystsSeptember 25, 2025 | marketbeat.comIs Tactile Systems Technology (TCMD) a Great Value Stock Right Now?September 24, 2025 | zacks.comIs Tactile Systems Technology, Inc.'s (NASDAQ:TCMD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?September 23, 2025 | finance.yahoo.comShould Value Investors Buy Tactile Systems Technology (TCMD) Stock?September 8, 2025 | zacks.comReturns At Tactile Systems Technology (NASDAQ:TCMD) Are On The Way UpSeptember 1, 2025 | finance.yahoo.comAre Investors Undervaluing Tactile Systems Technology (TCMD) Right Now?August 22, 2025 | zacks.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | msn.comIs Tactile Systems Technology (TCMD) Stock Undervalued Right Now?August 6, 2025 | zacks.comTactile Systems Technology (TCMD) Just Overtook the 20-Day Moving AverageAugust 6, 2025 | zacks.comTactile Systems Technology (TCMD) Recently Broke Out Above the 50-Day Moving AverageAugust 6, 2025 | zacks.comTactile Systems outlines 2025 revenue guidance of $310M-$315M while strengthening airway clearance growthAugust 6, 2025 | msn.comTactile Systems Technology, Inc. (TCMD) Q2 2025 Earnings Call TranscriptAugust 4, 2025 | seekingalpha.comTactile Systems Technology (TCMD) Surpasses Q2 Earnings and Revenue EstimatesAugust 4, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTCMD, INMD, MDXG, and RXST Company DescriptionsInMode NASDAQ:INMD$15.31 -0.17 (-1.10%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$15.31 0.00 (0.00%) As of 10/24/2025 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.MiMedx Group NASDAQ:MDXG$6.76 +0.12 (+1.81%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$6.68 -0.08 (-1.18%) As of 10/24/2025 06:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.RxSight NASDAQ:RXST$8.61 +0.18 (+2.14%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$8.72 +0.11 (+1.22%) As of 10/24/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.Tactile Systems Technology NASDAQ:TCMD$15.10 +0.15 (+1.00%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$15.09 -0.01 (-0.07%) As of 10/24/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 10/20 - 10/24 Freeport-McMoRan Posts Strong Earnings Despite Indonesia Shutdown Tractor Supply Stock Looks Like a Buy-and-Hold Winner Tesla’s Earnings Review: Does the Juice Justify the Squeeze? Warner Bros. Bidding War Potential: How High Could WBD Shares Go? Fal.Con Europe Could Be CrowdStrike’s Early Earnings Catalyst Logitech Eyes Breakout Before Earnings—Citigroup Sees 30% Upside Boeing Takes Off as FAA Greenlights 737 MAX Production Boost Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
